Physician

Isam Elias Marar, M.D.

According to 2025 Medicare claims, Isam Marar, M.D. (NPI: 1104976109) practices internal medicine in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Pottawattamie, IA. This provider's primary affiliated billing organization is WEST BROADWAY CLINIC, PC (NPI: 1407031230; TIN: 260359484) and primary practice location at 51501-3822. Marar is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), participating under the MSSP model.

Marar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 299 traditional Medicare patients, billed 3,679 HCPCS/CPT codes, and received $134,019 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 14,340 prescription claims across 485 beneficiaries totaling $2,524,103 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 509 claims. Open Payments data shows 208 records totaling $292,672. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $234,380 to $134,019. In contrast, Part D prescription costs have risen steadily, from $1,295,961 to $2,524,103. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $47,148 and ending at $52,212.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	681	11,124	$234,380
2016	606	9,426	$181,914
2017	562	11,045	$184,835
2018	512	7,251	$198,112
2019	457	6,608	$175,026
2020	398	8,523	$144,366
2021	363	4,969	$159,916
2022	341	5,234	$153,415
2023	326	3,883	$147,410
2024	299	3,679	$134,019

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	678	17,456	$1,295,961
2016	661	19,221	$1,455,487
2017	549	19,117	$1,565,915
2018	521	17,623	$1,737,105
2019	492	16,620	$1,967,776
2020	490	15,207	$1,900,451
2021	487	15,042	$2,223,944
2022	481	14,290	$2,428,690
2023	471	14,038	$2,628,368
2024	485	14,340	$2,524,103

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	355	1,263	$38,727
2016	325	1,132	$26,759
2017	245	965	$44,915
2018	265	976	$21,217
2019	243	990	$31,762
2020	186	886	$24,567
2021	191	776	$25,061
2022	202	865	$42,403
2023	155	701	$51,474
2024	111	509	$47,071

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	151	151	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	266	693	$75
G0444	Annual depression screening, 5 to 15 minutes	138	138	$17
36415	Insertion of needle into vein for collection of blood sample	271	773	$9
82043	Urine microalbumin (protein) level	127	132	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	345	10,870	$402,864
Ozempic	Semaglutide	282	11,624	$347,469
Farxiga	Dapagliflozin Propanediol	237	10,212	$192,468
Jardiance	Empagliflozin	132	6,601	$128,478
Tresiba Flextouch U-200	Insulin Degludec	94	4,186	$122,673

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	17	76	$26,291
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$5,501
E0784	External ambulatory infusion pump, insulin	Y	N/R	13	$3,946
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$1,831
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	43	132	$1,807

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	169	$3,257	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	39	$289,415	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Isam Elias Marar, M.D.?

Tedicare shows public-source Medicare data for Isam Elias Marar, M.D. (NPI 1104976109), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Isam Elias Marar, M.D. have ACO affiliation data?

Isam Elias Marar, M.D. is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273).

What billing organization is linked to Isam Elias Marar, M.D.?

Isam Elias Marar, M.D. is linked to WEST BROADWAY CLINIC, PC (billing NPI 1407031230) in the available physician profile data.

Does Isam Elias Marar, M.D. have Open Payments data?

Isam Elias Marar, M.D. has 208 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.